Internet Technology Based Life-style and Care Intervention for Risk Factors of Non Communicable Diseases(NCD)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04567121 |
|
Recruitment Status :
Recruiting
First Posted : September 28, 2020
Last Update Posted : September 28, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Lifestyle Intervention Non Communicable Diseases | Behavioral: Intensive intervention group Behavioral: standard intervention group | Not Applicable |
Cardiovascular and cerebrovascular diseases, diabetes, chronic obstructive pulmonary disease and malignant tumors are the main chronic diseases, which have been the most important cause of human death, consuming most health resources. In China, patients with cardiovascular and cerebrovascular diseases account for more than 40% of all causes of death. After half a century of research, we have a thorough understanding of risk factors of cardiovascular disease, including genetics, aging, ethnicity, physical activity decreases, unbalanced nutrition and calorie intake, smoking, obesity, hypertension, dyslipidemia, and glucose abnormalities, etc. Many factors can be corrected through health education, indicating that the occurrence of chronic diseases can be prevented through lifestyle changes and the control of risk factors.
This project collects risk factors of cardiovascular disease and establishes a real and reliable health database by conducting a cross-sectional survey of chronic diseases among residents of Tian Tong Yuan District (there are hundreds of thousands of people).On this basis, community health management network was established with internet technology. Meanwhile, prospective, open, community randomized and controlled lifestyle intervention studies were carried out. Intervention was conducted on risk factors of cardiovascular and cerebrovascular diseases, such as smoking, obesity, hypertension, lipid metabolism disorder, and hyperglycemia. For patients with chronic diseases, lifestyle intervention and health education should be carried out to improve the diagnosis rate and control rate. The project focuses on the impact of lifestyle interventions and health education on risk factor control, cardiovascular and cerebrovascular complications, diabetes and all-cause death.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 60000 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | Internet Technology Based Life-style and Care Intervention for Risk Factors of Non Communicable Diseases(NCD)-a Randomized, Controlled Trial in Communities Following up for 50 Years |
| Actual Study Start Date : | January 1, 2018 |
| Estimated Primary Completion Date : | January 1, 2070 |
| Estimated Study Completion Date : | December 1, 2070 |
| Arm | Intervention/treatment |
|---|---|
|
Intensive intervention group
intensive life-style and care intervention
|
Behavioral: Intensive intervention group
Establish a team of chronic disease prevention managers (5 people), with each educator responsible for the intervention of 200 people. For sub-health population and chronic disease patients, there would be conducted health education interview twice, 4 calls, online communication 50 times once a year, controlling risk factors and making treatment plan. |
|
Standard intervention group
standard life-style and care intervention
|
Behavioral: standard intervention group
Conduct general health education without active management |
- incidence rate of new noncommunicable diseases [ Time Frame: 2 year ]incidence rate of new noncommunicable diseases, for example, ASCVD, diabetes mellitus, hypertension
- incidence rate of major adverse cardiovascular events [ Time Frame: 2 years ]incidence rate of major adverse cardiovascular events, including nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death
- incidence rate of all-cause mortality [ Time Frame: 2 years ]incidence rate of all-cause mortality in the population
- score of quality of life (SF-36 scale) [ Time Frame: 2 years ]the improvement of quality of life
- Reduce the economic burden on health [ Time Frame: 2 years ]survey of health economic burden, calculate medical expenses
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 25 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Men and women older than 25 years of age with two or more risk factors as follows, BMI≥24 or BMI≤18.5 kg/m2, smoking, active exercise less than 30 minutes every day, blood pressure higher than 130/85 mmHg, dyslipidemia, fasting glucose higher than 6.1mmol/l, fatty liver.
- Patients with hypertension, diabetes and ASCVD
Exclusion Criteria:
- Patients had not signed the consent form
- Patients with severe heart failure, hepatic failure, renal failure and malignant tumor.
- Patients planing pregnancy
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04567121
| Contact: jianzhong xiao, PHD | +8613683685711 | xiaojzh858@sina.com |
| China, Beijing | |
| Beijing Tsinghua Changgung Hospital | Recruiting |
| Beijing, Beijing, China, Beijing, BJ 10 | |
| Contact: zhaoxiang liu, MD +8613718898419 lzxa01684@btch.edu.cn | |
| Study Director: | jianzhong xiao, PHD | Beijing Tsinghua Changgeng Hospital |
| Responsible Party: | Beijing Tsinghua Chang Gung Hospital |
| ClinicalTrials.gov Identifier: | NCT04567121 |
| Other Study ID Numbers: |
20281-0-01 |
| First Posted: | September 28, 2020 Key Record Dates |
| Last Update Posted: | September 28, 2020 |
| Last Verified: | September 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Internet Technology lifestyle intervention Non Communicable Diseases |
|
Noncommunicable Diseases Disease Attributes Pathologic Processes |

